Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment

This publication has 24 references indexed in Scilit:

• Effects of Two Years' Estrogen‐Gestagen Replacement on Climacteric Symptoms and Gonadotropins in the Early Postmenopausal Period
  Acta Obstetricia et Gynecologica Scandinavica, 1982
• Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy
  New England Journal of Medicine, 1981
• Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
  European Journal of Clinical Investigation, 1980
• Reduced Incidence of Endometrial Cancer among Postmenopausal Women Treated with Progestogens*
  Journal of the American Geriatrics Society, 1979
• ALTERED PLASMA LIPID AND LIPOPROTEIN LEVELS ASSOCIATED WITH ORAL CONTRACEPTIVE AND ŒSTROGEN USE: Report from the Medications Working Group of the Lipid Research Clinics Program
  The Lancet, 1979
• Effects of long-term estrogen replacement therapy
  American Journal of Obstetrics and Gynecology, 1979
• NATURAL ŒSTROGEN AS AN EFFECTIVE TREATMENT FOR TYPE-II HYPERLIPOPROTEINÆMIA IN POSTMENOPAUSAL WOMEN
  The Lancet, 1978
• POSTMENOPAUSAL ŒSTROGEN REPLACEMENT AND LIPIDS
  The Lancet, 1977
• Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. Stanford three-community study
  JAMA, 1976
• Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting.
  BMJ, 1975